How dialysis affects blood clotting in kidney patients
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial looks at how hemodialysis changes blood clotting in dialysis patients. It may help doctors understand why some people form clots and how to prevent them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a dialysis patient who has been on regular dialysis for at least 3 months.
- You are an adult (18 to 85 years old) and healthy, with no major diseases like diabetes, heart disease, or cancer.
- You have a confirmed blood clot (thrombosis) seen on an ultrasound or CT scan, and your D-dimer level is high.
- You are not taking blood-thinning medications like heparin that could affect the study results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways to manage atrial fibrillation (an irregular heartbeat) in people on dialysis. One approach uses a blood thinner called apixaban, and the other does not use blood thinners. The goal is to see which approach better prevents strokes and bleeding.
This trial compares two ways to prevent blood clots during a specific type of kidney dialysis called hemodiafiltration. If you have end-stage kidney disease and receive dialysis three times a week, this study may help doctors find the safest anticoagulation method for you.
This study looks at how often bleeding happens in people with chronic kidney disease who are taking blood thinners (anticoagulants) for conditions like blood clots, mechanical heart valves, or atrial fibrillation (an irregular heartbeat). It aims to identify risk factors for bleeding to help doctors manage treatment more safely.
This trial compares two types of blood thinners (vitamin K antagonists and factor Xa inhibitors) versus no blood thinner in people with atrial fibrillation who are on dialysis or have very advanced kidney disease. It aims to see which option is safest and most effective for preventing strokes and bleeds.
This trial studies whether taking aspirin can reduce heart and clot-related complications in adults receiving long-term dialysis. It may help by improving blood clotting behavior, but it also requires that aspirin is safe for you.
This study looks at how blood flow to the kidneys changes during hemodialysis in people who have just started dialysis. It may help doctors understand how to better protect kidney function.
Hear when a new Dialysis Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.